IXJ vs. ARKG
IXJ (iShares Global Healthcare ETF) and ARKG (ARK Genomic Revolution Multi-Sector ETF) are both Health & Biotech Equities funds. IXJ is passively managed, while ARKG is actively managed. Over the past 10 years, IXJ returned 7.66%/yr vs 7.22%/yr for ARKG. A 0.54 correlation means they provide meaningful diversification when combined. IXJ charges 0.46%/yr vs 0.75%/yr for ARKG.
Performance
IXJ vs. ARKG - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, IXJ achieves a -5.26% return, which is significantly lower than ARKG's 17.09% return. Over the past 10 years, IXJ has outperformed ARKG with an annualized return of 7.66%, while ARKG has yielded a comparatively lower 7.22% annualized return.
IXJ
- 1D
- 0.39%
- 1M
- 0.34%
- YTD
- -5.26%
- 6M
- -4.88%
- 1Y
- 9.30%
- 3Y*
- 4.42%
- 5Y*
- 4.02%
- 10Y*
- 7.66%
ARKG
- 1D
- -0.24%
- 1M
- 10.92%
- YTD
- 17.09%
- 6M
- 10.02%
- 1Y
- 53.35%
- 3Y*
- 0.67%
- 5Y*
- -15.72%
- 10Y*
- 7.22%
IXJ vs. ARKG - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
IXJ iShares Global Healthcare ETF | -5.26% | 14.99% | 0.55% | 3.62% | -4.94% | 19.60% | 12.74% | 23.23% | 2.83% | 20.44% |
ARKG ARK Genomic Revolution Multi-Sector ETF | 17.09% | 23.04% | -28.24% | 16.22% | -53.90% | -33.92% | 180.40% | 44.00% | -1.26% | 46.61% |
Correlation
The correlation between IXJ and ARKG is 0.47, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.47 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.46 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.49 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.53 |
Correlation (All Time) Calculated using the full available price history since Nov 3, 2014 | 0.54 |
The correlation between IXJ and ARKG has been stable across timeframes, ranging from 0.46 to 0.54 - a consistent structural relationship.
IXJ vs. ARKG - Sectors Allocation Comparison
Sectors
IXJ
ARKG
Healthcare
Consumer Defensive
-
Basic Materials
-
-
Communication Services
-
-
Consumer Cyclical
-
-
Energy
-
-
Financial Services
-
Industrials
-
-
Real Estate
-
-
Technology
-
-
Utilities
-
-
Healthcare
IXJ
ARKG
Consumer Defensive
IXJ
ARKG
-
Basic Materials
IXJ
-
ARKG
-
Communication Services
IXJ
-
ARKG
-
Consumer Cyclical
IXJ
-
ARKG
-
Energy
IXJ
-
ARKG
-
Financial Services
IXJ
-
ARKG
Industrials
IXJ
-
ARKG
-
Real Estate
IXJ
-
ARKG
-
Technology
IXJ
-
ARKG
-
Utilities
IXJ
-
ARKG
-
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
IXJ vs. ARKG — Risk / Return Rank
IXJ
ARKG
IXJ vs. ARKG - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for iShares Global Healthcare ETF (IXJ) and ARK Genomic Revolution Multi-Sector ETF (ARKG). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| IXJ | ARKG | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 0.64 | 1.31 | -0.66 |
Sortino ratioReturn per unit of downside risk | 1.06 | 1.99 | -0.93 |
Omega ratioGain probability vs. loss probability | 1.12 | 1.22 | -0.10 |
Calmar ratioReturn relative to maximum drawdown | 0.87 | 1.95 | -1.08 |
Martin ratioReturn relative to average drawdown | 2.11 | 4.67 | -2.56 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| IXJ | ARKG | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.64 | 1.31 | -0.66 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.28 | -0.35 | +0.63 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.49 | 0.18 | +0.31 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.42 | 0.13 | +0.29 |
Drawdowns
IXJ vs. ARKG - Drawdown Comparison
The maximum IXJ drawdown since its inception was -40.60%, smaller than the maximum ARKG drawdown of -83.59%. Use the drawdown chart below to compare losses from any high point for IXJ and ARKG.
Loading charts...
Drawdown Indicators
| IXJ | ARKG | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -40.60% | -83.59% | +42.99% |
Max Drawdown (1Y)Largest decline over 1 year | -10.78% | -27.51% | +16.73% |
Max Drawdown (3Y)Largest decline over 3 years | -18.14% | -51.96% | +33.82% |
Max Drawdown (5Y)Largest decline over 5 years | -18.14% | -80.18% | +62.04% |
Max Drawdown (10Y)Largest decline over 10 years | -27.35% | -83.59% | +56.24% |
Current DrawdownCurrent decline from peak | -9.27% | -69.65% | +60.38% |
Average DrawdownAverage peak-to-trough decline | -6.92% | -35.87% | +28.95% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 4.41% | 11.46% | -7.05% |
Volatility
IXJ vs. ARKG - Volatility Comparison
The current volatility for iShares Global Healthcare ETF (IXJ) is 3.75%, while ARK Genomic Revolution Multi-Sector ETF (ARKG) has a volatility of 11.90%. This indicates that IXJ experiences smaller price fluctuations and is considered to be less risky than ARKG based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| IXJ | ARKG | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 3.75% | 11.90% | -8.15% |
Volatility (6M)Calculated over the trailing 6-month period | 10.05% | 28.77% | -18.72% |
Volatility (1Y)Calculated over the trailing 1-year period | 14.55% | 41.12% | -26.57% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 14.21% | 45.61% | -31.40% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 15.67% | 41.12% | -25.45% |
IXJ vs. ARKG - Expense Ratio Comparison
IXJ has a 0.46% expense ratio, which is lower than ARKG's 0.75% expense ratio.
Dividends
IXJ vs. ARKG - Dividend Comparison
IXJ's dividend yield for the trailing twelve months is around 1.47%, while ARKG has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
ARKG ARK Genomic Revolution Multi-Sector ETF | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.62% | 0.85% | 3.14% | 0.82% | 1.34% | 0.00% | 0.00% |
IXJ iShares Global Healthcare ETF | 1.47% | 1.40% | 1.50% | 1.38% | 1.17% | 1.12% | 1.27% | 1.42% | 2.11% | 1.46% | 1.73% | 2.85% |
Frequently Asked Questions
IXJ and ARKG have a correlation of 0.47, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
ARKG has higher volatility (11.90%) compared to IXJ (3.75%). In terms of maximum drawdown, IXJ dropped -40.60% vs ARKG's -83.59%.
On 10-year performance, IXJ leads with 7.66% vs 7.22% for ARKG. On fees, IXJ is cheaper at 0.46% per year. On volatility, IXJ has been the lower-risk option at 3.75%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 10-year period, IXJ has performed better with a 7.66% return vs 7.22%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
IXJ is cheaper with a 0.46% expense ratio, compared with 0.75% for ARKG.
IXJ has the higher dividend yield at 1.47%, compared with 0.00% for ARKG.
They also come from different issuers: iShares and ARK. Their fees differ too: 0.46% for IXJ and 0.75% for ARKG.
ARKG currently has the higher Sharpe Ratio (1.31 vs 0.64), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for IXJ and ARKG
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer